Usted buscó: macrocyclic (Inglés - Maltés)

ivermectin is a member of the macrocyclic lactone class of endectocides.
ivermectin huwa membru tal- klassi tal- macrocyclic lactone ta 'l- endektoċidi.

milbemycin oxime is an antiparasitic endectocide belonging to the macrocyclic lactones.
milbemycin oxime hu endektoċida kontra l-parassiti li jappartjeni għal lactones makroċikliċi.

during treatment with advocate no other antiparasitic macrocyclic lactone should be administered.
waqt il-kura tal-advocate ma jista’ jiġi amministrat l-ebda laktonju makroċikliku ieħor kontra l- parrassiti.

pharmacotherapeutic group: antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins.
grupp farmako-terapewtiku: prodotti anti-parassitiċi, insettiċidi u ripellanti, lattoni makroċikliċi, milbemiċini.

some dog breeds may present increased susceptibility to macrocyclic lactones, potentially leading to signs of neurotoxicity.
xi razez tal-klieb jistgħu jimmanifestaw suxxettibilita’ akbar għal-lactones makroċikliċi, li potenzjalment twassal għal sinjali ta’ newrotossiċità.

exceptionally, as with other macrocyclic lactones, reversible neurological signs have been observed after use of the product.
kif jiġri ma ’ macrocyclic lactones oħrajn, f’ każijiet eċċezzjonali, wara li jintuża l- prodott ġew osservati sinjali newroloġiċi li huma riversibbli.

metabolites identified in faeces were formed via oxidation at the macrocyclic moiety or aromatic moiety or both and by o-demethylation followed by oxidation.
il-metaboliti identifikati fl-ippurgar kienu fformati permezz tal-ossidazzjoni tal-moijetà makroċiklika jew moijetà aromatika jew it-tnejn u b’o-demetilazzjoni segwiti minn ossidazzjoni.

emodepside may interact with other veterinary medicinal products using the same transport system (e.g. macrocyclic lactones).
emodepside jista’ jinteraġġixxi ma’ prodotti mediċinali veterinarji oħrajn li jużaw l-istess sistema ta’ trasport tal-mediċina (eż. lattoni makroċikliċi).

moxidectin, 23-(o-methyloxime)-f28249 alpha is a second-generation macrocyclic lactone of the milbemycin family.
14 m´għandux effett fuq is- sistema ċentrali ta´l- annimali li jreddgħu.

milbemycin oxime is a systemic macrocyclic lactone containing two major factors, a3 and a4 (ratio of a3:a4 is 20:80).
milbemycin oxime hu lactone makroċikliku sistemiku li fih żewġ fatturi maġġuri, a3 u a4 (il- proporzjon ta’ a3:a4 hu ta’ 20:80).

co-treatment with other drugs that are p-glycoprotein substrates/ inhibitors (for example, ivermectin and other antiparasitic macrocyclic lactones,
trattament flimkien ma ’ mediċina oħra li hija substrat/ inibitur tal- p- glajkoprotejn (eż. ivermektina, u lattoni makroċikliċi oħra kontra l- parassiti, eritromiċina, prednisolon u ċiklosporin) jista ’ jirriżulta f’ effetti farmakokinetiċi mediċinali.

co-treatment with other drugs that are p-glycoprotein substrates/inhibitors (for example, ivermectin and other antiparasitic macrocyclic lactones, erythromycin, prednisolone and cyclosporine) could give rise to pharmacokinetic drug interactions.
trattament flimkien ma’ mediċini oħra li huma substrat/inibitur għal p-glajkoprotejn (eż. ivermektin, u lattoni makroċikliċi oħra kontra l-parassiti, eritromiċina, prednisolon u ċiklosporin) jistgħu jirriżultaw f’effetti farmakokinetiċi fuq xulxin.